Pediatric-Onset Multiple Sclerosis Tied to Lasting Social Consequences
WEDNESDAY, Feb. 24, 2021 -- Pediatric-onset multiple sclerosis (PoMS) is associated with less educational achievement, lower earnings, and greater use of disability benefits throughout the working-age life span, according to a study published online Feb. 22 in JAMA Neurology.
Kyla A. McKay, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues examined the associations between PoMS and educational level and income throughout adulthood. Nationwide microdata from linked Swedish registers was used to identify 485 patients with PoMS diagnosed from 1980 to 2014 and 4,850 age- and sex-matched controls without MS.
The researchers found that individuals with PoMS were less likely than matched controls to attend university (odds ratio, 0.80) and had significantly lower annual earnings than the reference cohort (−$1,618 in the youngest age period to −$10,683 in the oldest). Higher rates of disability benefits, as recorded by sickness absence days in the youngest age period (rate ratio, 3.06) and disability pension days in the oldest age period (rate ratio, 1.43), were seen among people with PoMS.
"This study suggests that PoMS may have lasting consequences that translate into lower educational achievements and earnings and a greater use of disability benefits in adulthood," the authors write.
Several authors disclosed financial ties to biotechnology and pharmaceutical companies.
© 2021 HealthDay. All rights reserved.
Posted: February 2021
Read this next
TUESDAY, April 20, 2021 -- A machine learning algorithm can use data from brain magnetic resonance imaging (MRI) to identify subtypes of multiple sclerosis (MS), according to a...
THURSDAY, April 15, 2021 -- For patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) receiving anti-CD20 treatment, B-cell repopulation occurs...
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 15 to 19, 2021. This roundup...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.